Atara Biotherapeutics, Inc.

LSE:0HIY Stock Report

Market Cap: US$65.7m

Atara Biotherapeutics Management

Management criteria checks 1/4

Atara Biotherapeutics' CEO is Cokey Nguyen, appointed in Sep 2024, has a tenure of less than a year. total yearly compensation is $2.28M, comprised of 23.7% salary and 76.3% bonuses, including company stock and options. directly owns 0.33% of the company’s shares, worth $214.44K. The average tenure of the management team and the board of directors is 1.3 years and 5 years respectively.

Key information

Cokey Nguyen

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage23.7%
CEO tenureless than a year
CEO ownership0.3%
Management average tenure1.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Cokey Nguyen's remuneration changed compared to Atara Biotherapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$133m

Jun 30 2024n/an/a

-US$181m

Mar 31 2024n/an/a

-US$233m

Dec 31 2023US$2mUS$540k

-US$276m

Compensation vs Market: Cokey's total compensation ($USD2.28M) is above average for companies of similar size in the UK market ($USD348.94K).

Compensation vs Earnings: Insufficient data to compare Cokey's compensation with company performance.


CEO

Cokey Nguyen (51 yo)

less than a year

Tenure

US$2,277,691

Compensation

Dr. Anhco Nguyen, Ph D., also known as Cokey, has been the President, Chief Executive Officer and Director of Atara Biotherapeutics Inc. since September 09, 2024. He served as Chief Scientific Officer at A...


Leadership Team

NamePositionTenureCompensationOwnership
Anhco Nguyen
Presidentless than a yearUS$2.28m0.33%
$ 214.4k
Eric Hyllengren
Executive VP1.7yrsno data0.19%
$ 127.4k
Alex Chapman
Vice President of Corporate Communications & Investor Relationsno datano datano data
Jill Henrich
Executive VP & Chief Regulatory officer4.3yrsno data0.16%
$ 105.7k
Rajani Dinavahi
Senior VP & Chief Medical Officerless than a yearno datano data

1.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 0HIY's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Anhco Nguyen
Presidentless than a yearUS$2.28m0.33%
$ 214.4k
William Heiden
Independent Director9.1yrsUS$237.23k0.11%
$ 69.3k
Matthew Fust
Independent Director10.8yrsUS$239.73k0.036%
$ 23.7k
Carol Gallagher
Lead Independent Director11.9yrsUS$260.23k0.29%
$ 192.7k
Gregory Ciongoli
Independent Directorless than a yearno datano data
Ameet Mallik
Independent Director3.3yrsUS$219.52k0.014%
$ 9.4k
Maria Roncarolo
Independent Director4.6yrsUS$229.73k0.022%
$ 14.4k
Pascal Touchon
Chairman of the Board5.5yrsUS$4.38m0.49%
$ 323.1k

5.0yrs

Average Tenure

59yo

Average Age

Experienced Board: 0HIY's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Atara Biotherapeutics, Inc. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John NewmanCanaccord Genuity
Yigal NochomovitzCitigroup Inc
Jonathan MillerEvercore ISI